Revenue (Annual)

Revenue: The sum of all revenue fields included for a company's operating activities.

Nutex Health Inc. (NUTX) had Revenue of $479.95M for the most recently reported fiscal year, ending 2024-12-31.

Quarterly Annual

Figures for fiscal year ending 2024-12-31

Income Statement Financials
Revenue	$479.95M
Net Income	$52.10M
Cost of Goods Sold	$283.69M
Gross Profit	$196.26M
Operating Expenses	$349.25M
Operating Income	$130.70M
Non-Operating Income/Expense	$-20.87M
Pre-Tax Income	$109.83M
Normalized Pre-Tax Income	$109.83M
Income after Taxes	$94.81M
Income from Continuous Operations	$94.81M
Consolidated Net Income/Loss	$94.81M
Normalized Income after Taxes	$94.81M
EBIT	$130.70M
EBITDA	$150.12M
Weighted-Average Shares Outstanding (Basic)	5.09M
Weighted-Average Shares Outstanding (Diluted)	5.49M
Earnings per Share (EPS) (Basic)	$10.23
Earnings per Share (EPS) (Diluted)	$9.69
Balance Sheet Financials
Current Assets	$292.48M
Property, Plant, and Equipment	$77.93M
Long-Term Assets	$362.84M
Total Assets	$655.32M
Current Liabilities	$154.23M
Long-Term Debt	$281.94M
Long-Term Liabilities	$312.56M
Total Liabilities	$466.79M
Common Equity	$188.53M
Tangible Shareholders Equity	$159.08M
Shareholders Equity	$188.53M
Common Shares Outstanding	5.51M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$23.15M
Cash Flow from Investing Activities	$-5.61M
Cash Flow from Financial Activities	$1.09M
Beginning Cash	$22.00M
End Cash	$40.64M
Increase/Decrease in Cash	$18.64M
Stock-Based Compensation	$16.55M
Common Stock Dividends Paid	$-6.44M
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	1.90
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.60
Debt to Equity Ratio	1.63
Gross Margin	40.89%
Operating Margin	27.23%
EBIT Margin	27.23%
EBITDA Margin	31.28%
Pre-Tax Profit Margin	22.88%
Profit Margin	10.85%
Free Cash Flow	$20.85M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.73
Inventory Turnover	99.55
Receiveable Turnover	2.03
Days Sales in Receivables	179.52
Return on Equity	50.29%
Return on Tangible Equity	59.60%
Return on Assets	14.47%
Return on Investments	20.15%
Book Value Per Share	$34.21
Free Cash Flow per Share	$3.80
Operating Cash Flow per Share	$4.22

Data from Zacks Investment Research, Inc.